A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.
Clinical trial NCT07106229 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07106229
- Sponsor
- Magellan Stem Cells
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2028-02-01
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.